Capital Bank & Trust’s Rockwell Medical RMTI Stock Holding History

Capital Bank & Trust’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-95	Closed	-$11K	–	382
2020 Q4	$11K	Buy	+95	New	+$10.6K	﹤0.01%	360

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Capital Bank & Trust's RMTI Position: Q1 2021 in Review

Capital Bank & Trust sold out of Rockwell Medical (RMTI) in Q1 2021, closing a stake of 95 shares — an estimated $11K sold.

Capital Bank & Trust first reported a position in RMTI in Q4 2020 and held it in 1 quarter. The position peaked at $11K in Q4 2020. 89 funds tracked by Wall St. Rank hold RMTI as of Q1 2021.

Capital Bank & Trust reported no remaining Rockwell Medical position as of Q1 2021 after selling out during the quarter.
Capital Bank & Trust sold 95 Rockwell Medical shares in Q1 2021, an estimated $11K.
Capital Bank & Trust first reported a position in Rockwell Medical in Q4 2020 and held it in 1 quarter.
Capital Bank & Trust's Rockwell Medical position peaked at $11K in Q4 2020.
89 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2021.

Based on Capital Bank & Trust's 13F filing for Q1 2021, filed 14 May 2021.